National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 70849-70850 [2022-25318]

Download as PDF Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices lotter on DSK11XQN23PROD with NOTICES1 • 93.137 Community Programs to Improve Minority Health Grant Program • 93.217 Family Planning Services • 93.260 Family Planning Personnel Training • 93.297 Teenage Pregnancy Prevention Program • 98.343 Public Health Service Evaluation Funds • 93.344 Research, Monitoring and Outcomes Definitions for Vaccine Safety • 93.974 Family Planning Service Delivery Improvement Research Grants Full Assistance Listing descriptions are published and updated annually on https://sam.gov. Co-sponsors will work with OASH/GAM staff to jointly develop an event. Both OASH and the co-sponsor must contribute substantively to the development of the event. OASH Grants Workshops may be convened over one to three days; conducted virtually, in-person, or in a hybrid format (virtual and in-person). Depending on the workshop format and scope, a workshop may typically accommodate between 100 and 500 attendees. Co-sponsors can charge registration fees to recover costs associated with the events; however, co-sponsors may not set registration fees at an amount higher than necessary to recover related event expenses. Further, co-sponsors are solely responsible for collecting and handling any registration fees collected. Eligibility for Co-Sponsorship: The cosponsoring entity must have a demonstrated interest and experience in building capacity among potential grant applicants and grant recipients, particularly with respect to programs supported by GAM. The co-sponsoring entity must participate substantively in the co-sponsored activity, not just provide funding, logistical services, or other material support. Each potential co-sponsorship’s expression of interest shall describe: (1) The entity’s interest in building capacity among potential grant applicants and grant recipients, (2) The entity’s prior experience and current readiness to undertake the responsibilities described above, (3) The type of event(s) that the entity is interested in co-sponsoring with GAM, (4) Facilities and/or virtual platforms available for the event(s), and (5) Any current constraints with respect to dates or facilities. The type of event may be a special topic of mutual interest with one or VerDate Sep<11>2014 21:25 Nov 18, 2022 Jkt 259001 70849 more of the aforementioned GAM supported program offices and may be developed jointly. The expression of interest should be a bulleted outline, no more than two pages in length, single-spaced, and 11point font. An entity may submit an expression of interest individually or jointly with other entities describing their relative contributions. Evaluation Criteria: After engaging in exploratory discussions with potential co-sponsors that respond to this notice, the following considerations will be used by HHS officials, as appropriate and relevant, to select the co-sponsor(s): DEPARTMENT OF HEALTH AND HUMAN SERVICES • Qualifications and capability to fulfill co-sponsorship responsibilities • Suitability of the location of the proposed OASH Grants Workshops in terms of the overall geographical distribution of OASH Grants Workshops • Potential for reaching, generating, and engaging an adequate number of attendees who may be potential grant applicants and grant recipients • Availability and description of facilities and resources needed to support the OASH Grants Workshop • Availability of administrative support for the logistics of hosting such OASH Grants Workshops Dated: November 16, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. These duties will be outlined in a cosponsorship agreement with GAM and the sponsoring program office(s) that will set forth the details of the cosponsored activity, including the requirements that any fees collected by the co-sponsor shall be limited to the amount necessary to cover the cosponsor’s related event expenses. This co-sponsorship agreement does not represent an endorsement by HHS, OASH, GAM or its supported program office(s) of an individual co-sponsor’s policies, positions, or activities. Additionally, this agreement will not affect any determination concerning activities by the co-sponsors that are regulated by GAM’s grant-supporting offices. Dated: November 14, 2022. Scott J. Moore, Director, Grants and Acquisitions Management Division, Office of the Assistant Secretary for Health. [FR Doc. 2022–25259 Filed 11–18–22; 8:45 am] BILLING CODE 4150–28–P PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 National Institutes of Health National Library of Medicine; Cancellation of Meeting Notice is hereby given of the cancellation of the National Library of Medicine Special Emphasis Panel, March 16, 2023, 11 a.m. to 3 p.m., Virtual Meeting, which was published in the Federal Register on October 6, 2022, 87 FR 193 Page Number 60696. This notice is being amended to announce that the meeting is cancelled and will not be rescheduled. [FR Doc. 2022–25317 Filed 11–18–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; RFA–DK–22–004 NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership. Date: December 16, 2022. Time: 2:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2 Democracy, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: John F. Connaughton, Ph.D., Chief, Scientific Review Branch, Review Branch, DEA, Niddk National Institutes of Health, Room 7007, 6707 E:\FR\FM\21NON1.SGM 21NON1 70850 Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–7797 connaughtonj@ extra.niddk.nih.gov. Information is also available on the Institute’s/Center’s home page: www.niddk.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: November 16, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–25318 Filed 11–18–22; 8:45 am] I. Background and Purpose of the Test BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Vessel Entrance and Clearance Automation Test U.S. Customs and Border Protection, DHS. ACTION: General notice. AGENCY: This document announces that U.S. Customs and Border Protection (CBP) will conduct the Vessel Entrance and Clearance Automation Test. This test will allow participants to submit certain vessel entry and clearance data and requests to CBP electronically through the Vessel Entrance and Clearance System (VECS), instead of submitting paper forms, as currently required by CBP regulations. Specifically, this test will allow participants to submit the data required on CBP Forms 26, 226, 1300, 1302, 1303, 1304, and 3171 electronically through VECS prior to arrival or departure from designated ports. This notice describes the test, sets forth the eligibility requirements for participation, and invites public comment on any aspect of the test. DATES: The test will begin at the Port of Gulfport in Gulfport, Mississippi, no earlier than December 21, 2022 and will continue for 24 months from the date the test begins. During the 24 months, additional ports will be designated as test ports, and CBP will announce the additional ports participating in the test on its website. Comments concerning this notice and all aspects of the announced test may be submitted at any time during the test period. ADDRESSES: Written comments concerning any aspect of the test should lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 21:25 Nov 18, 2022 Jkt 259001 be submitted via email to Brian Sale, Branch Chief, Cargo and Conveyance Security, Manifest Conveyance and Security Division, Office of Field Operations, U.S. Customs and Border Protection, at OFO-ManifestBranch@ cbp.dhs.gov. In the subject line of the email, please write ‘‘Comments on Vessel Entrance and Clearance Automation Test.’’ FOR FURTHER INFORMATION CONTACT: Brian Sale, Branch Chief, Cargo and Conveyance Security, Manifest Conveyance and Security Division, Office of Field Operations, U.S. Customs & Border Protection; OFOManifestBranch@cbp.dhs.gov. SUPPLEMENTARY INFORMATION: A. Purpose of the Test U.S. Customs and Border Protection (CBP) regulations generally require that the master or vessel agent 1 of a commercial vessel submit certain arrival, entrance, and clearance data to CBP when traveling to and from U.S. ports of entry. See part 4 of title 19 of the Code of Federal Regulations (19 CFR part 4). The vessel agent must generally submit this data to CBP on paper forms. Some of the data collected through these forms is redundant or already available to CBP through other required data submission platforms, such as data required by the applicable U.S. Coast Guard (USCG) regulations. See 33 CFR 160.201–216. Executive Order 13659, ‘‘Streamlining the Export/Import Process for America’s Businesses,’’ signed in February 2014, requires the U.S. Government to streamline the export/import process for America’s businesses by increasing efforts to improve technologies, policies, and other controls governing the movement of goods across U.S. borders. In support of this Executive Order, as well as in response to requests from the trade industry, CBP is developing a web-based system that will allow for the partial automation and electronic filing of many of its paper-based commercial vessel arrival, entrance, and clearance data collections. The Vessel Entrance and Clearance Automation Test (‘‘the Test’’) will allow CBP to test this system. The Test will also fulfill CBP’s aims to improve service delivery and customer experience, by reducing paperwork burdens and promoting 1 For the purposes of this document, ‘‘vessel agent’’ may include a vessel master or commanding officer, authorized agent, operator, owner, consignee, or a third party contracted by the owner or operator of the vessel to prepare and submit Entrance and Clearance documentation to CBP on behalf of the vessel owner or operator. PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 greater efficiency with respect to the submission of vessel entry and clearance forms. Specifically, the Test will allow participants to electronically submit to CBP, through the Vessel Entrance and Clearance System (VECS), when seeking to enter into or depart from a designated port, the entrance and clearance data that is currently collected on CBP Form 1300: Vessel Entrance or Clearance Statement; CBP Form 1302: Inward Cargo Declaration; CBP Form 1303: Ship’s Stores Declarations; CBP Form 1304: Crew’s Effects Declaration; CBP Form 3171: Application-Permit-SpecialLicense-Unlading-Lading-Overtime Services; CBP Form 26: Report of Diversion; and CBP Form 226: Record of Vessel Foreign Repair or Equipment Purchase. The Test will also allow participants to make certain entry and clearance requests and reports. Additionally, the Test will allow vessel agents to submit required supporting documentation, such as vessel certificates, to CBP electronically. CBP will then use the data and documentation submitted through VECS to process vessel entrances and clearances electronically at designated ports. VECS is intended to modernize the maritime commercial entry and clearance process upon the arrival and departure of a commercial vessel at U.S. ports by eliminating the need for vessel agents to fill out and submit data elements that are requested on more than one of these forms or through other required data submission methods, and instead consolidate the maritime entry and clearance process into an electronic submission to a single platform. All other CBP forms required for the entrance and clearance of a vessel (e.g., CBP Form 1302A: Cargo Declaration Outward with Commercial Forms; CBP Form I–418: Passenger List-Crew List; 2 and CBP Form 5129: Crew Member’s Declaration) are not part of the Test and must continue to be submitted in accordance with the procedures outlined in the CBP regulations. The current process for entering and clearing a commercial vessel generally involves the manual preparation and presentation of paper forms (originals and copies), even though in some cases, CBP regulations allow for electronic submissions. VECS will provide a webbased interface that can be accessed by both vessel agents and CBP on a mobile 2 As of February 28, 2022, CBP’s amended regulations require vessel operators and vessel agents to submit the data elements required on CBP Form I–418 electronically via the U.S. Coast Guard’s electronic Notice of Arrival/Departure (eNOA/D) system. See 86 FR 73618. E:\FR\FM\21NON1.SGM 21NON1

Agencies

[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Pages 70849-70850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25318]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; RFA-DK-22-004 NIDDK 
Partnerships with Professional Societies to Enhance Scientific 
Workforce Diversity and Promote Scientific Leadership.
    Date: December 16, 2022.
    Time: 2:00 p.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute of 
Diabetes and Digestive and Kidney Diseases, 2 Democracy, 6707 
Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: John F. Connaughton, Ph.D., Chief, Scientific 
Review Branch, Review Branch, DEA, Niddk National Institutes of 
Health, Room 7007, 6707

[[Page 70850]]

Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7797 
[email protected].

    Information is also available on the Institute's/Center's home 
page: www.niddk.nih.gov/, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: November 16, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-25318 Filed 11-18-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.